Literature DB >> 10743631

[Stimulation of primary osteoblast cultures with rh-TGF-beta, rh-bFGF, rh-BMP 2 and rx-BMP 4 in an in vitro model].

S Kessler1, S Kastler, U Mayr-Wohlfart, W Puhl, K P Günther.   

Abstract

Bone metabolism is influenced by systemic and local acting hormons. Bone morphogenetic proteins (BMPs) as representatives of the latter substances are known to have the ability for ectopic bone formation. Within this study, we investigated the influence of different growth factors on the proliferation- and differentiation rate of osteoblast-like cells. For that purpose, human osteoblast-like cells (HPOC) were incubated in the presence of either recombinant BMP-4 of the genome of xenopus laevis (rxBMP-4), recombinant human BMP 2 (rhBMP-2), transforming growth factor-beta (TGF-beta) or basic fibroblast growth factor (rh-bFGF) in two different concentrations each (10 ng/ml and 50 ng/ml). Cell proliferation was measured within a MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromid] assay, the amount of cell differentiation by the activity of alcaline phosphatase. Rx-BMP-4 induced a differentiation of HPOC to almost the same extent as rhBMP-2, whereas the addition of rh-bFGF, applied at the same concentration, failed to have any influence on cell differentiation. However, rh-bFGF provoked an increase in cell proliferation when compared with unstimulated HPOC, while rhBMP-2 and rxBMP-4 showed no effect on proliferation. TGF-beta influenced bone proliferation as well as differentiation significantly. The equipotent effect of recombinant human BMP-2 and recombinant BMP-4 obtained from Xenopus laevis with regard to differentiation and proliferation of human primary osteoblast-like cells originates either in the fact that target cells have receptors for BMP 2 as well as BMP 4, or that both BMP's link to the same receptor with almost the same affinity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10743631     DOI: 10.1007/s001320050017

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  5 in total

1.  [Applying an osteoinductive protein complex for regeneration of osseous defects].

Authors:  F R Kloss; K A Schlegel; E Felszeghy; S Falk; J Wiltfang
Journal:  Mund Kiefer Gesichtschir       Date:  2004-01-20

2.  Expression of cytokines IL-4, IL-12, IL-15, IL-18, and IFNgamma and modulation by different growth factors in cultured human osteoblast-like cells.

Authors:  C Ruiz; E Pérez; O García-Martínez; L Díaz-Rodríguez; M Arroyo-Morales; C Reyes-Botella
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

Review 3.  Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives.

Authors:  Cornelius von Wilmowsky; Tobias Moest; Emeka Nkenke; Florian Stelzle; Karl Andreas Schlegel
Journal:  Oral Maxillofac Surg       Date:  2013-02-24

4.  [Osseous defect regeneration using autogenous bone alone or combined with Biogran or Algipore with and without added thrombocytes. A microradiologic evaluation].

Authors:  K A Schlegel; F R Kloss; S Schultze-Mosgau; F W Neukam; J Wiltfang
Journal:  Mund Kiefer Gesichtschir       Date:  2003-02-14

5.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.